These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34174269)

  • 1. PEX5 prevents cardiomyocyte hypertrophy via suppressing the redox-sensitive signaling pathways MAPKs and STAT3.
    Wang M; Li J; Ding Y; Cai S; Li Z; Liu P
    Eur J Pharmacol; 2021 Sep; 906():174283. PubMed ID: 34174269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 Suppression Is Involved in the Protective Effect of SIRT6 Against Cardiomyocyte Hypertrophy.
    Zhang X; Li W; Shen P; Feng X; Yue Z; Lu J; You J; Li J; Gao H; Fang S; Li Z; Liu P
    J Cardiovasc Pharmacol; 2016 Sep; 68(3):204-14. PubMed ID: 27124607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1/2.
    Dong B; Xue R; Sun Y; Dong Y; Liu C
    Mol Cell Biochem; 2017 Sep; 433(1-2):113-123. PubMed ID: 28497371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKCζ interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy.
    Li J; Gao H; Huang J; Wang P; Huang Y; Luo W; Zhang X; Shen P; You J; Cai S; Li Z; Liu P
    J Pharmacol Sci; 2016 Sep; 132(1):15-23. PubMed ID: 27094369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
    Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
    J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy.
    Meng C; Su H; Shu M; Shen F; Lu Y; Wu S; Su Z; Yu M; Yang D
    Cell Death Dis; 2024 Sep; 15(9):683. PubMed ID: 39294131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pinoresinol diglucoside (PDG) attenuates cardiac hypertrophy via AKT/mTOR/NF-κB signaling in pressure overload-induced rats.
    Chen Y; Pan R; Zhang J; Liang T; Guo J; Sun T; Fu X; Wang L; Zhang L
    J Ethnopharmacol; 2021 May; 272():113920. PubMed ID: 33607200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy.
    Cheng TH; Shih NL; Chen CH; Lin H; Liu JC; Chao HH; Liou JY; Chen YL; Tsai HW; Chen YS; Cheng CF; Chen JJ
    J Biomed Sci; 2005; 12(1):123-33. PubMed ID: 15864745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of angiopoietin-like protein 4 in phenylephrine-induced cardiomyocyte hypertrophy.
    Sun Y; Li Y; Liu C; Xue R; Dong B; Huang H; Peng L; Liu J; Dong Y
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 29339422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ERK1/2/PPARα/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine.
    Huang Q; Huang J; Zeng Z; Luo J; Liu P; Chen S; Liu B; Pan X; Zang L; Zhou S
    Life Sci; 2015 Mar; 124():41-9. PubMed ID: 25636810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes.
    Takahashi N; Saito Y; Kuwahara K; Harada M; Tanimoto K; Nakagawa Y; Kawakami R; Nakanishi M; Yasuno S; Usami S; Yoshimura A; Nakao K
    J Mol Cell Cardiol; 2005 Jan; 38(1):185-92. PubMed ID: 15623435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transactivated EGFR mediates α₁-AR-induced STAT3 activation and cardiac hypertrophy.
    Li Y; Zhang H; Liao W; Song Y; Ma X; Chen C; Lu Z; Li Z; Zhang Y
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1941-51. PubMed ID: 21856923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SENP1 Protects Against Pressure Overload-Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling.
    Yang D; Fan D; Guo Z; Liu FY; Wang MY; An P; Yang Z; Tang QZ
    J Am Heart Assoc; 2022 Nov; 11(22):e027004. PubMed ID: 36370010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT3 improved peroxisomes-mitochondria interplay and prevented cardiac hypertrophy via preserving PEX5 expression.
    Wang M; Ding Y; Hu Y; Li Z; Luo W; Liu P; Li Z
    Redox Biol; 2023 Jun; 62():102652. PubMed ID: 36906951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
    Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
    Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha Mangostin Derived from Garcinia magostana Linn Ameliorates Cardiomyocyte Hypertrophy and Fibroblast Phenotypes in Vitro.
    Sari N; Katanasaka Y; Sugiyama Y; Miyazaki Y; Sunagawa Y; Funamoto M; Shimizu K; Shimizu S; Hasegawa K; Morimoto T
    Biol Pharm Bull; 2021; 44(10):1465-1472. PubMed ID: 34602555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REDD1 attenuates cardiac hypertrophy via enhancing autophagy.
    Liu C; Xue R; Wu D; Wu L; Chen C; Tan W; Chen Y; Dong Y
    Biochem Biophys Res Commun; 2014 Nov; 454(1):215-20. PubMed ID: 25450383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte.
    Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z
    Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CaMKIIδ meditates phenylephrine induced cardiomyocyte hypertrophy through store-operated Ca
    Ji Y; Guo X; Zhang Z; Huang Z; Zhu J; Chen QH; Gui L
    Cardiovasc Pathol; 2017; 27():9-17. PubMed ID: 27940402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different contributions of STAT3, ERK1/2, and PI3-K signaling to cardiomyocyte hypertrophy by cardiotrophin-1.
    Tian ZJ; Cui W; Li YJ; Hao YM; Du J; Liu F; Zhang H; Zu XG; Liu SY; Chen L; An W
    Acta Pharmacol Sin; 2004 Sep; 25(9):1157-64. PubMed ID: 15339391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.